News Conference News ACC 2025 RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show. Michael O'Riordan April 08, 2025
Presentation ACC 2025 Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial Presenter: William Fearon March 30, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation ACC 2025 Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial Presenter: Joo-Yong Hahn March 29, 2025
Presentation ACC 2025 Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT Presenter: Hyo-Soo Kim March 29, 2025
Presentation CTO 2025 Sex-Based Differences on Clinical Outcomes in High-Risk Percutaneous Coronary Intervention with Left Ventricular Assist Devices Presenter: Ogechukwu Samuel Obi March 01, 2025
News Conference News ACC 2025 RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up By Michael O'Riordan April 08, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization By Yael L. Maxwell April 07, 2025
News Conference News ACC 2025 Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE By Caitlin E. Cox April 02, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI By Michael O'Riordan April 02, 2025